Developmental control of synaptic receptivity
Our experienced team, led by Travis Sugg, ensures that each treatment is custom to your specific needs, maximizing the potential for a speedy recovery
Take your time
AD patients also display additional biomarkers including cerebrovascular pathology and vascular dysfunctions, decreases in cerebral blood flow, cerebrovascular reactivity, and neurovascular coupling, leading to brain deficits in oxygen and nutrient delivery [4,5]
On regulatory status, the picture is straightforward and important
Clinicians therefore need to know not only the half-life of the drug that they are prescribing but also what the half-life might be given the presence of one or more of these factors in the patient to whom the drug is being prescribed